Related references
Note: Only part of the references are listed.Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration
Tara E. Tracy et al.
CELL (2022)
Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease
Sarah E. Carnemolla et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
Adenosine receptor signalling in Alzheimer's disease
Phuc N. H. Trinh et al.
PURINERGIC SIGNALLING (2022)
Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders
Sebastien Delhaye et al.
MOLECULAR PSYCHIATRY (2021)
Brain's immune cells put the brakes on neurons
Thomas Pfeiffer et al.
NATURE (2020)
Negative feedback control of neuronal activity by microglia
Ana Badimon et al.
NATURE (2020)
Screening of a neuronal cell model of tau pathology for therapeutic compounds
Marcus Pickhardt et al.
NEUROBIOLOGY OF AGING (2019)
Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice
Julia Gamache et al.
NATURE COMMUNICATIONS (2019)
Olfactory and other sensory impairments in Alzheimer disease
Claire Murphy
NATURE REVIEWS NEUROLOGY (2019)
18F-FDG-PET in Mouse Models of Alzheimer's Disease
Caroline Bouter et al.
FRONTIERS IN MEDICINE (2019)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau
Joseph McInnes et al.
NEURON (2018)
Why do so many clinical trials of therapies for Alzheimer's disease fail?
Roy M. Anderson et al.
LANCET (2017)
Anti-aggregant tau mutant promotes neurogenesis
Maria Joseph et al.
MOLECULAR NEURODEGENERATION (2017)
Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration
Jocelyn Stockwell et al.
MOLECULES (2017)
Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy
Thomas Blackmore et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity
Marta Anglada-Huguet et al.
NEUROBIOLOGY OF DISEASE (2016)
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280
Frank J. A. Dennissen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A(2A) adenosine receptor deletion is protective in a mouse model of Tauopathy
C. Laurent et al.
MOLECULAR PSYCHIATRY (2016)
Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca++ dysregulation
Jochen Martin Decker et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
Katja Hochgraefe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Olfactory bulb involvement in neurodegenerative diseases
Johannes Attems et al.
ACTA NEUROPATHOLOGICA (2014)
Tau-aggregation inhibitor therapy for Alzheimer's disease
Claude M. Wischik et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Prostaglandin E2 EP1 Receptor Antagonist Improves Motor Deficits and Rescues Memory Decline in R6/1 Mouse Model of Huntington's Disease
Marta Anglada-Huguet et al.
MOLECULAR NEUROBIOLOGY (2014)
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer's Disease
Tara L. Spires-Jones et al.
NEURON (2014)
Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology
Katja Hochgraefe et al.
FEBS JOURNAL (2013)
Tauopathies and Tau Oligomers
Akihiko Takashima
JOURNAL OF ALZHEIMERS DISEASE (2013)
A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease
Simona Gabriella Di Santo et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Structural Determinants of Tau Aggregation Inhibitor Potency
Kelsey N. Schafer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors
Lars Messing et al.
NEUROBIOLOGY OF AGING (2013)
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
Ann Van der Jeugd et al.
ACTA NEUROPATHOLOGICA (2012)
Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease
Ana Ricobaraza et al.
HIPPOCAMPUS (2012)
Deciphering Alzheimer Disease
Dennis Selkoe et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
Eva-Maria Mandelkow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity
Weifeng Xu
CURRENT OPINION IN NEUROBIOLOGY (2011)
Reversibility of Tau-Related Cognitive Defects in a Regulatable FTD Mouse Model
Astrid Sydow et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Early Improved and Late Defective Cognition Is Reflected by Dendritic Spines in Tau.P301L Mice
Anna Kremer et al.
JOURNAL OF NEUROSCIENCE (2011)
Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant
Astrid Sydow et al.
JOURNAL OF NEUROSCIENCE (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Adenosine A1 receptor antagonists in clinical research and development
Berthold Hocher
KIDNEY INTERNATIONAL (2010)
Rolofylline, an Adenosine A(sub 1)-Receptor Antagonist, in Acute Heart Failure.
Barry M. Massie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system
Ming-Chang Chiang et al.
HUMAN MOLECULAR GENETICS (2009)
Synaptic Activity Reduces Intraneuronal Aβ, Promotes APP Transport to Synapses, and Protects against Aβ-Related Synaptic Alterations
Davide Tampellini et al.
JOURNAL OF NEUROSCIENCE (2009)
Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference
Stephen M. Smith et al.
NEUROIMAGE (2009)
Hypometabolism as a therapeutic target in Alzheimer's disease
Lauren C. Costantini et al.
BMC NEUROSCIENCE (2008)
The potential for β-structure in the repeat domain of Tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy
Maria-Magdalena Mocanu et al.
JOURNAL OF NEUROSCIENCE (2008)
The β-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy
Katrin Eckermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Early detection of Alzheimer's disease using neuroimaging
Lisa Mosconi et al.
EXPERIMENTAL GERONTOLOGY (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human α-mannosidosis
R D'Hooge et al.
JOURNAL OF NEUROSCIENCE (2005)
Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
LM Billings et al.
NEURON (2005)
Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease
L Mosconi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
The neurobiology of consolidations, or, how stable is the engram?
Y Dudai
ANNUAL REVIEW OF PSYCHOLOGY (2004)
Dendrite and dendritic spine alterations in Alzheimer models
DL Moolman et al.
JOURNAL OF NEUROCYTOLOGY (2004)
In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography
A Bauer et al.
NEUROIMAGE (2003)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
The relationship between amyloid and tau
J Hardy
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
S Oddo et al.
NEUROBIOLOGY OF AGING (2003)
Food intake, water intake, and drinking spout side preference of 28 mouse strains
AA Bachmanov et al.
BEHAVIOR GENETICS (2002)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
Declining brain activity in cognitively normal apolipoprotein E ε4 heterozygotes:: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
EM Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The role and regulation of adenosine in the central nervous system
TV Dunwiddie et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
GW Small et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure
M von Bergen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
